- (-%)
Range 0.250 - 0.255   (2%)
Open 0.255
Previous Close 0.250
Buy Price 0.250
Buy Volume 17.6
Sell Price 0.255
Sell Volume 69.9
Volume 1,071.7
Value 268,126
Measurement Type Value
EPS (SGD) -0.015
Trailing EPS (SGD) -0.011
NAV (SGD) 0.024
Cash In Hand (SGD) 0.014
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 10.593
Price / Cash In Hand 18.382
Issued & Paid-up Shares 696,853,000
Treasury Shares -
Market Cap (M) 174.213
Par Value (SGD) n.a.
Beta - 75 Days -0.136
R-Squared - 75 Days(%) 0.2
Beta - 500 Days 0.521
R-Squared - 500 Days(%) 1.4
ISIN Code SG1BD9000009
Under CPF Investment Scheme (CPFIS) No
Index Components FTSE ST Catalist Index
Delayed prices. Updated at 25 Feb 2021 17:16.
Data powered by
View All Events

About IX Biopharma

iX Biopharma Ltd. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of therapies for the treatment of acute and breakthrough pain, and male erectile dysfunction. Its segments include Specialty Pharmaceutical and Chemical Analysis segments. The Specialty Pharmaceutical segment is engaged in the development, manufacturing and sale of pharmaceutical products. The Chemical Analysis segment is engaged in the provision of laboratory testing services. Its products are Wafermine, which is a sublingual ketamine oral wafer that contains the non-opioid drug for the management of moderate to severe pain; Bnox, which is a sublingual buprenorphine oral wafer that is developed as a formulation for moderate to severe pain; PheoniX, which is used for the treatment of male erectile dysfunction; WaferRest, which is used for the alleviation of jet lag and improving sleep quality, and Wafernyl, which is used for breakthrough cancer pain.

Loading Chart...